Prostate cancer screening can save lives but ‘absolute benefit is small’, study says

What happened

According to The Guardian’s source item, Prostate cancer screening can save lives but ‘absolute benefit is small’, study says, Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment Screening for prostate cancer with a blood test can save men’s lives, but the “absolute benefit is small” and many men could face unnecessary treatment and medical complications, according to the most comprehensive study yet. In a review that analysed six trials involving nearly 800,000 men, screening with the prostate-specific antigen (PSA) test reduced prostate cancer deaths by two for every 1,000 men screened, meaning 500 men must be screened to prevent one death from the disease. Continue reading…

Context

The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-05-15T00:00:21+00:00.

What to watch

Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.

Source

Primary source: Prostate cancer screening can save lives but ‘absolute benefit is small’, study says via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.